Design and Content Validation using Expert Opinions of an Instrument Assessing the Lifestyle of Adults: The 'PONTE A 100' Questionnaire.

Lifestyle, a major determinant of health status, comprises a number of habits and behaviours that form a part of daily life. People with healthy lifestyles have a better quality of life, suffer less disease, and have a longer life expectancy. This work reports the design and content validation of a questionnaire-the 'PONTE A 100' questionnaire-assessing the lifestyle of adults. This collects information across five dimensions-'Eating Habits', 'Physical Activity', 'Smoking and use of Alcohol and other Drugs', 'Emotional Wellbeing', and 'Safety and Non-intentional Injuries'-via the answering of a total 33 items. Psychometric validation of the instrument's content was obtained via expert opinions. This was performed by two rounds of assessment and involved 34 experts representing different health science disciplines (mean experience, 27.4 ± 9.4 years). At the end of each round, adjustments were made according to their recommendations. Agreement between the experts was examined using the Aiken V test. A final V value of 0.95 (95% CI, 0.90-1.00) was obtained for the questionnaire as a whole, highlighting the validity of its content. The questionnaire would therefore appear to be an appropriate instrument for assessing the lifestyle of adults.

Control del paciente diabético en Atención Primaria: influencia de cartera de servicios y otros factores / Diabetic patient control in Primary Care: Influence of service portfolio and other factors

OBJETIVO: Estudiar el efecto del tipo de seguimiento según la cartera de servicios y de otros factores asociados en la disminución de las cifras de HbA1c en personas con diabetes mellitus tipo 2, nuevo diagnóstico y con mal control inicial. DISEÑO: Estudio observacional analítico de una cohorte en condiciones de práctica clínica habitual. EMPLAZAMIENTO: 262 centros de salud de Atención Primaria de Madrid. Participantes: 1838 personas mayores de 18 años con nuevo diagnóstico de diabetes y cifras de HbA1c inicial ≥ 7% o ≥ 8,5% si tienen más de 75 años. Intervenciones: La variable exposición fue el tipo de seguimiento según la cartera, categorizado en mínimo, medio y óptimo, según el número de intervenciones realizadas y periodicidad por tipo de plan terapéutico-farmacológico. MEDICIONES PRINCIPALES: Se estudiaron comorbilidad, plan terapéutico-farmacológico, consejos dieta y ejercicio, índice de privación. La variable resultado principal fue la diferencia entre la HbA1c final e inicial. RESULTADOS: Tras 2 años de seguimiento se produjo una disminución media de la HbA1c de -1,7 puntos porcentuales (IC del 95%: -1,6; -1,8), siendo 0,39 puntos mayor en los pacientes con tipo de seguimiento óptimo: -2,1 (IC del 95%: -1,7; -2,4). Los factores asociados a la disminución fueron: tipo de seguimiento óptimo -0,29 (IC del 95%: -0,5; -0,1) y medio -0,26 (IC del 95%: -0,5; -0,0), y valor de la HbA1c inicial -0,9 (IC del 95%: -0,9; -0,9) y los factores asociados al aumento: tratamiento con insulina y vivir en zonas socialmente desfavorecidas. CONCLUSIONES: Los pacientes con diagnóstico reciente de diabetes en los que se realiza un seguimiento óptimo según la cartera de servicios mejoran el control glucémico

OBJECTIVE: To study the effect of the type of follow-up according to Service Portfolio and other associated factors, in the reduction of HbA1c levels in people with a new diagnosis of type 2 diabetes and poor initial control. DESIGN: Analytical observational study of a cohort under routine clinical practice conditions. Location: 262 Primary Health Care Centres in Madrid. PARTICIPANTS: 1,838 individuals older than 18 years with a new diagnosis of type 2 DM and initial HbA1c levels ≥ 7%, or ≥ 8.5% if older than 75 years. Interventions: The exposure variable was the type of follow-up according to Portfolio, categorised as minimum, medium, and optimal, according to the number of interventions performed and periodicity of type of therapeutic-pharmacological plan. MAIN MEASUREMENTS: A study was made of the comorbidity, therapeutic-pharmacological plan, diet - exercise advice and deprivation index. The main outcome was the difference between the final and initial HbA1c. RESULTS: After 2 years of follow-up there was a mean decrease in HbA1c by -1.7 percentage points (95% CI: -1.6;-1.8), which was 0.36 points higher in patients with optimal follow-up: -2.1 (95% CI: -1.7;-2.4). The factors associated with a decrease in HbA1c were the optimal follow-up -0.29 (95% CI: -0.5;-0.1), the medium follow-up -0.26 (95% CI: -0.5; -0.0), and the initial HbA1c value -0.9 (95% CI: -0.9; -0.9. The factors associated with the increase were insulin treatment and living in socially disadvantaged areas. CONCLUSIONS: Glycaemic control was improved in patients with a new diagnosis of diabetes in which optimal follow-up is performed as proposed in the Service Portfolio

[Diabetic patient control in Primary Care: Influence of service portfolio and other factors]. / Control del paciente diabético en Atención Primaria: influencia de cartera de servicios y otros factores.

OBJECTIVE: To study the effect of the type of follow-up according to Service Portfolio and other associated factors, in the reduction of HbA1c levels in people with a new diagnosis of type 2 diabetes and poor initial control. DESIGN: Analytical observational study of a cohort under routine clinical practice conditions. LOCATION: 262 Primary Health Care Centres in Madrid. PARTICIPANTS: 1,838 individuals older than 18 years with a new diagnosis of type 2 DM and initial HbA1c levels ≥ 7%, or ≥ 8.5% if older than 75 years. INTERVENTIONS: The exposure variable was the type of follow-up according to Portfolio, categorised as minimum, medium, and optimal, according to the number of interventions performed and periodicity of type of therapeutic-pharmacological plan. MAIN MEASUREMENTS: A study was made of the comorbidity, therapeutic-pharmacological plan, diet - exercise advice and deprivation index. The main outcome was the difference between the final and initial HbA1c. RESULTS: After 2 years of follow-up there was a mean decrease in HbA1c by -1.7 percentage points (95% CI: -1.6;-1.8), which was 0.36 points higher in patients with optimal follow-up: -2.1 (95% CI: -1.7;-2.4). The factors associated with a decrease in HbA1c were the optimal follow-up -0.29 (95% CI: -0.5;-0.1), the medium follow-up -0.26 (95% CI: -0.5; -0.0), and the initial HbA1c value -0.9 (95% CI: -0.9; -0.9. The factors associated with the increase were insulin treatment and living in socially disadvantaged areas. CONCLUSIONS: Glycaemic control was improved in patients with a new diagnosis of diabetes in which optimal follow-up is performed as proposed in the Service Portfolio.